Skip navigation

Improve Access and Outcomes Across the Care Continuum

August 21-22, 2019
  • Philadelphia, PA

Driven by payer reform, technological and scientific advances and consumer demands, the healthcare industry is undergoing unprecedented transformation. The shift from volume- to value-based payment and care delivery has driven healthcare providers to reshape their approach and many have answered the call for personalized, convenient and coordinated patient care by forming large organizations such as IDNs and ACOs.

Understanding these complex health systems and how they interact with all of the industry’s stakeholders is crucial for manufacturers to better support and meet the needs of these growing networks.

To address the challenges and opportunities ahead, join a distinguished group of industry pioneers at CBI’s 4th Annual Partnering with IDNs BioPharma Strategy Summit, for a highly collaborative meeting on refining care coordination, increasing patient engagement and adherence, and ultimately, improving patient outcomes.

ATTENDEE ACCLAIM FROM THE PARTNERING WITH IDNS SERIES:

Great networking with the experts on specialty pharma and IDNs. Thought-provoking topics filled the agenda. Highly recommend this conference.

Regional Account Manager II, Biopharmaceuticals, Novo Nordisk

This conference is a great forum to create partnerships between manufacturers and health systems. Information is shared that helps create a symbiotic relationship.

Vanderbilt University Medical Center

Well organized and good speaker selection.” Assistant Director, Specialty Pharmacy Services.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The content was current and helped to frame future thinking, allowing us to compare what we are doing, to what others may need in order to create a successful partnership

Pfizer

Consistently this conference pushes my thinking into the future and provides a view of what is ‘around the corner’ in healthcare.

Director–Key Account Lead, Joint Health and Renal, Sanofi Biosurgery

4th Annual Partnering with IDNs BioPharma Strategy Summit

Improve Access and Outcomes Across the Care Continuum

Driven by payer reform, technological and scientific advances and consumer demands, the healthcare industry is undergoing unprecedented transformation. The shift from volume- to value-based payment and care delivery has driven healthcare providers to reshape their approach and many have answered the call for personalized, convenient and coordinated patient care by forming large organizations such as IDNs and ACOs.

Understanding these complex health systems and how they interact with all of the industry’s stakeholders is crucial for manufacturers to better support and meet the needs of these growing networks.

To address the challenges and opportunities ahead, join a distinguished group of industry pioneers at CBI’s 4th Annual Partnering with IDNs BioPharma Strategy Summit, for a highly collaborative meeting on refining care coordination, increasing patient engagement and adherence, and ultimately, improving patient outcomes.

ATTENDEE ACCLAIM FROM THE PARTNERING WITH IDNS SERIES:

Great networking with the experts on specialty pharma and IDNs. Thought-provoking topics filled the agenda. Highly recommend this conference.

Regional Account Manager II, Biopharmaceuticals, Novo Nordisk

This conference is a great forum to create partnerships between manufacturers and health systems. Information is shared that helps create a symbiotic relationship.

Vanderbilt University Medical Center

Well organized and good speaker selection.” Assistant Director, Specialty Pharmacy Services.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The content was current and helped to frame future thinking, allowing us to compare what we are doing, to what others may need in order to create a successful partnership

Pfizer

Consistently this conference pushes my thinking into the future and provides a view of what is ‘around the corner’ in healthcare.

Director–Key Account Lead, Joint Health and Renal, Sanofi Biosurgery